Revenue (Tables)

6 Months Ended

Jun. 30, 2022

Revenue

Schedule of revenue recognized from collaborative arrangements

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands)	2022		2021		2022		2021
Viatris collaboration agreement - Amounts receivable from Viatris	$	10,878	$	10,934	$	21,565	$	21,319

Schedule of collaborative amounts were recorded in the Company's condensed consolidated statements of operations

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands)	2022		2021		2022		2021
Alfasigma	$	166	$	3	$	169	$	7
Viatris		6		6		12		12
Janssen		—		1,971		—		5,833
Total collaboration revenue	$	172	$	1,980	$	181	$	5,852

Summary of the reductions to R&D costs related to reimbursement payments

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands)	2022		2021		2022		2021
Viatris	$	1,543	$	67	$	3,079	$	161
Janssen		—		1,193		—		2,525
Total reduction to R&D expense, net	$	1,543	$	1,260	$	3,079	$	2,686